Gilead Sciences ROE 2006-2020 | GILD

Current and historical return on equity (ROE) values for Gilead Sciences (GILD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Gilead Sciences ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-06-30 $-0.26B $18.14B -1.23%
2020-03-31 $4.96B $22.18B 22.47%
2019-12-31 $5.39B $22.65B 24.42%
2019-09-30 $2.69B $20.74B 12.37%
2019-06-30 $5.96B $22.75B 26.65%
2019-03-31 $5.89B $22.09B 26.67%
2018-12-31 $5.46B $21.53B 25.10%
2018-09-30 $1.59B $23.01B 7.39%
2018-06-30 $2.21B $21.73B 10.02%
2018-03-31 $3.46B $20.65B 15.48%
2017-12-31 $4.63B $20.50B 20.62%
2017-09-30 $11.60B $25.25B 52.36%
2017-06-30 $12.21B $23.09B 60.51%
2017-03-31 $12.64B $20.92B 68.54%
2016-12-31 $13.50B $19.36B 80.78%
2016-09-30 $15.08B $17.36B 90.54%
2016-06-30 $16.35B $16.12B 97.31%
2016-03-31 $17.34B $14.02B 102.44%
2015-12-31 $18.11B $19.11B 101.62%
2015-09-30 $16.91B $17.94B 99.50%
2015-06-30 $15.04B $16.63B 94.16%
2015-03-31 $14.21B $17.59B 89.21%
2014-12-31 $12.10B $15.82B 80.92%
2014-09-30 $9.41B $13.86B 67.50%
2014-06-30 $7.46B $16.43B 56.26%
2014-03-31 $4.58B $13.70B 38.19%
2013-12-31 $3.08B $11.75B 27.54%
2013-09-30 $3.05B $11.19B 28.70%
2013-06-30 $2.93B $11.34B 29.32%
2013-03-31 $2.87B $10.39B 31.25%
2012-12-31 $2.59B $9.54B 30.74%
2012-09-30 $2.50B $8.75B 32.13%
2012-06-30 $2.56B $8.08B 35.87%
2012-03-31 $2.59B $7.36B 38.90%
2011-12-31 $2.80B $6.87B 43.99%
2011-09-30 $2.77B $6.23B 44.74%
2011-06-30 $2.73B $6.21B 44.79%
2011-03-31 $2.70B $6.18B 43.37%
2010-12-31 $2.90B $6.12B 44.28%
2010-09-30 $3.07B $5.88B 46.25%
2010-06-30 $3.04B $6.70B 45.99%
2010-03-31 $2.90B $7.50B 46.28%
2009-12-31 $2.64B $6.51B 46.66%
2009-09-30 $2.39B $5.75B 46.58%
2009-06-30 $2.22B $5.31B 46.74%
2009-03-31 $2.08B $5.02B 47.76%
2008-12-31 $1.98B $4.47B 50.31%
2008-09-30 $1.79B $4.17B 48.62%
2008-06-30 $1.69B $3.77B 49.97%
2008-03-31 $1.67B $3.33B 54.32%
2007-12-31 $1.58B $3.46B 56.00%
2007-09-30 $-0.45B $2.98B -18.74%
2007-06-30 $-0.90B $2.49B -36.17%
2007-03-31 $-1.05B $2.38B -39.12%
2006-12-31 $-1.19B $1.82B -40.68%
2006-09-30 $0.76B $3.30B 23.48%
2006-06-30 $0.99B $3.20B 32.34%
2006-03-31 $0.92B $3.39B 32.20%
2005-12-31 $0.81B $3.03B 32.23%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $85.893B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $139.879B 10.77
Amgen (AMGN) United States $139.495B 15.15
CSL (CSLLY) Australia $90.737B 0.00
Vertex Pharmaceuticals (VRTX) United States $69.995B 39.06
Regeneron Pharmaceuticals (REGN) United States $66.917B 24.75
Illumina (ILMN) United States $51.942B 59.99
Biogen (BIIB) United States $47.535B 8.13
Moderna (MRNA) United States $28.414B 0.00
Seattle Genetics (SGEN) United States $27.439B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.605B 0.00
Genmab (GMAB) Denmark $23.557B 19.38
Alexion Pharmaceuticals (ALXN) United States $22.329B 9.30
Genmab (GNMSF) Denmark $21.977B 65.25
BioMarin Pharmaceutical (BMRN) United States $21.445B 155.59
Incyte (INCY) United States $20.628B 0.00
BeiGene (BGNE) Cayman Islands $18.710B 0.00
BioNTech SE (BNTX) Germany $16.732B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.070B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.658B 36.64
Bio-Rad Laboratories (BIO.B) United States $15.061B 68.12
Exact Sciences (EXAS) United States $12.757B 0.00
Sarepta Therapeutics (SRPT) United States $12.482B 0.00
Galapagos (GLPG) Belgium $11.942B 43.27
ARGENX SE-ADR (ARGX) Netherlands $10.728B 0.00
QIAGEN (QGEN) Netherlands $10.579B 26.85
Novavax (NVAX) United States $10.346B 0.00
Bio-Techne Corp (TECH) United States $9.858B 68.23
Immunomedics (IMMU) United States $9.458B 0.00
Guardant Health (GH) United States $8.543B 0.00
Repligen (RGEN) United States $7.760B 123.18
Ascendis Pharma (ASND) Denmark $7.571B 0.00
Emergent Biosolutions (EBS) United States $6.890B 27.29
Exelixis (EXEL) United States $6.714B 24.42
ACADIA Pharmaceuticals (ACAD) United States $6.511B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.370B 197.33
Vir Biotechnology (VIR) United States $6.272B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.177B 15.37
Mirati Therapeutics (MRTX) United States $5.825B 0.00
Acceleron Pharma (XLRN) United States $5.727B 0.00
MyoKardia (MYOK) United States $5.548B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.159B 0.00
Adaptive Biotechnologies (ADPT) United States $4.822B 0.00
Zai Lab (ZLAB) China $4.628B 0.00
Sorrento Therapeutics (SRNE) United States $4.555B 0.00
Bluebird Bio (BLUE) United States $4.355B 0.00
NeoGenomics (NEO) United States $4.344B 1311.33
China Biologic Products (CBPO) China $4.174B 23.20
Blueprint Medicines (BPMC) United States $4.163B 0.00
MorphoSys AG (MOR) Germany $4.053B 53.12
Amicus Therapeutics (FOLD) United States $3.924B 0.00
Halozyme Therapeutics (HALO) United States $3.890B 0.00
Global Blood Therapeutics (GBT) United States $3.740B 0.00
Arena Pharmaceuticals (ARNA) United States $3.694B 0.00
Denali Therapeutics (DNLI) United States $3.560B 0.00
Reata Pharmaceuticals (RETA) United States $3.470B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.360B 0.00
Fate Therapeutics (FATE) United States $3.126B 0.00
Insmed (INSM) United States $3.067B 0.00
Inovio Pharmaceuticals (INO) United States $3.002B 0.00
Alkermes (ALKS) Ireland $2.954B 61.92
Principia Biopharma (PRNB) United States $2.812B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.699B 0.00
Amarin (AMRN) Ireland $2.695B 0.00
Twist Bioscience (TWST) United States $2.449B 0.00
Mesoblast (MESO) Australia $2.035B 0.00
Editas Medicine (EDIT) United States $1.961B 0.00
Viela Bio (VIE) United States $1.916B 0.00
Ligand Pharmaceuticals (LGND) United States $1.908B 64.49
PHARMA MAR SA (PHMMF) Spain $1.866B 0.00
UniQure (QURE) Netherlands $1.838B 0.00
Sangamo Therapeutics (SGMO) United States $1.760B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.740B 0.00
Seres Therapeutics (MCRB) United States $1.731B 0.00
I-Mab (IMAB) China $1.683B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.682B 40.04
Revance Therapeutics (RVNC) United States $1.663B 0.00
Eidos Therapeutics (EIDX) United States $1.655B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.532B 0.00
Adverum Biotechnologies (ADVM) United States $1.502B 0.00
Zealand Pharma (ZEAL) Denmark $1.430B 0.00
Zymeworks (ZYME) Canada $1.408B 0.00
Mersana Therapeutics (MRSN) United States $1.374B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.365B 0.00
Coherus BioSciences (CHRS) United States $1.340B 7.81
NGM Biopharmaceuticals (NGM) United States $1.304B 0.00
Intra-Cellular Therapies (ITCI) United States $1.293B 0.00
Epizyme (EPZM) United States $1.290B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Cytokineticsorporated (CYTK) United States $1.268B 0.00
REGENXBIO (RGNX) United States $1.266B 0.00
Beam Therapeutics (BEAM) United States $1.241B 0.00
NantKwest (NK) United States $1.217B 0.00
Alcobra (ARCT) United States $1.214B 0.00
Intellia Therapeutics (NTLA) United States $1.199B 0.00
Akcea Therapeutics (AKCA) United States $1.182B 0.00
Alector (ALEC) United States $1.148B 0.00
Arvinas (ARVN) United States $1.144B 0.00
Compugen (CGEN) Israel $1.121B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.077B 0.00
Arcus Biosciences (RCUS) United States $1.057B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.036B 0.00
Retrophin (RTRX) United States $0.975B 0.00
Heska (HSKA) United States $0.962B 0.00
VBI Vaccines (VBIV) United States $0.958B 0.00
Athenex (ATNX) United States $0.950B 0.00
Myriad Genetics (MYGN) United States $0.915B 47.19
Intrexon (PGEN) United States $0.882B 0.00
Dynavax Technologies (DVAX) United States $0.853B 0.00
Morphic Holding (MORF) United States $0.852B 0.00
Pharming Group (PHGUF) Netherlands $0.851B 19.43
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.846B 0.00
Cara Therapeutics (CARA) United States $0.806B 0.00
Codexis (CDXS) United States $0.782B 0.00
Cellectis S.A (CLLS) France $0.743B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.728B 0.00
Vericel (VCEL) United States $0.723B 0.00
Castle Biosciences (CSTL) United States $0.715B 0.00
Kadmon Holdings (KDMN) United States $0.714B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.711B 0.00
Frequency Therapeutics (FREQ) United States $0.700B 0.00
MiMedx (MDXG) United States $0.674B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.652B 5.71
Sinovac Biotech (SVA) China $0.640B 20.87
Agenus (AGEN) United States $0.622B 0.00
Cue Biopharma (CUE) United States $0.599B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.587B 0.00
Syros Pharmaceuticals (SYRS) United States $0.572B 0.00
UROGEN PHARMA (URGN) United States $0.552B 0.00
MeiraGTx Holdings (MGTX) United States $0.524B 0.00
Kala Pharmaceuticals (KALA) United States $0.519B 0.00
Athersys (ATHX) United States $0.509B 0.00
Prothena (PRTA) Ireland $0.508B 0.00
Protagonist Therapeutics (PTGX) United States $0.495B 0.00
Anika Therapeutics (ANIK) United States $0.491B 21.46
AnaptysBio (ANAB) United States $0.482B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.478B 0.00
Innate Pharma S.A (IPHA) France $0.471B 0.00
BioDelivery Sciences (BDSI) United States $0.463B 32.79
Aquinox Pharmaceuticals (NLTX) United States $0.461B 0.00
Cel-Sci (CVM) United States $0.453B 0.00
AC Immune SA (ACIU) Switzerland $0.453B 0.00
Prometic Life Sciences (LMNL) Canada $0.439B 0.00
IBio (IBIO) United States $0.437B 0.00
Scholar Rock Holding (SRRK) United States $0.427B 0.00
Avid Bioservices (CDMO) United States $0.426B 0.00
Puma Biotechnology (PBYI) United States $0.418B 0.00
ANI Pharmaceuticals (ANIP) United States $0.408B 9.61
Albireo Pharma (ALBO) United States $0.400B 0.00
Clovis Oncology (CLVS) United States $0.396B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.395B 0.00
Kamada (KMDA) Israel $0.383B 15.93
Merus (MRUS) Netherlands $0.383B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.370B 0.00
MannKind (MNKD) United States $0.364B 0.00
PDL BioPharma (PDLI) United States $0.362B 0.00
Precision BioSciences (DTIL) United States $0.355B 0.00
CytomX Therapeutics (CTMX) United States $0.352B 0.00
WAVE Life Sciences (WVE) Singapore $0.337B 0.00
Trevena (TRVN) United States $0.335B 0.00
Geron (GERN) United States $0.333B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.302B 0.00
ChromaDex (CDXC) United States $0.298B 0.00
Biofrontera AG (BFRA) Germany $0.297B 0.00
OSMOTICA PHARM (OSMT) United States $0.296B 0.00
Arbutus Biopharma (ABUS) United States $0.296B 0.00
Affimed (AFMD) Germany $0.294B 0.00
Starpharma Holdings (SPHRY) Australia $0.291B 0.00
Selecta Biosciences (SELB) United States $0.290B 0.00
Cellular Biomedicine (CBMG) United States $0.290B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.289B 0.00
Spero Therapeutics (SPRO) United States $0.279B 0.00
Menlo Therapeutics (MNLO) United States $0.277B 0.00
NextCure (NXTC) United States $0.276B 0.00
Fortress Biotech (FBIO) United States $0.274B 0.00
Pfenex (PFNX) United States $0.263B 0.00
ADMA Biologics Inc (ADMA) United States $0.262B 0.00
DBV Technologies S.A (DBVT) France $0.256B 0.00
Northwest Biotherapeutics (NWBO) United States $0.255B 0.00
Abeona Therapeutics (ABEO) United States $0.250B 0.00
Dyadic (DYAI) United States $0.245B 0.00
Celldex Therapeutics (CLDX) United States $0.241B 0.00
HOOKIPA Pharma (HOOK) United States $0.241B 0.00
Verastem (VSTM) United States $0.241B 0.00
IVERIC Bio (ISEE) United States $0.233B 0.00
Pluristem Therapeutics (PSTI) Israel $0.229B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.226B 0.00
Strongbridge Biopharma (SBBP) United States $0.223B 0.00
Cerecor (CERC) United States $0.214B 0.00
Exicure (XCUR) United States $0.208B 0.00
Aduro Biotech (ADRO) United States $0.208B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.207B 9.65
Theratechnologies (THTX) Canada $0.199B 0.00
Sutro Biopharma (STRO) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.195B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.195B 0.00
Five Prime Therapeutics (FPRX) United States $0.189B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Aptinyx (APTX) United States $0.187B 0.00
XOMA (XOMA) United States $0.186B 0.00
VTv Therapeutics (VTVT) United States $0.173B 0.00
Liquidia Technologies (LQDA) United States $0.168B 0.00
Cyclerion Therapeutics (CYCN) United States $0.166B 0.00
Aytu Bioscience (AYTU) United States $0.166B 0.00
Eton Pharmaceuticals (ETON) United States $0.164B 0.00
Cidara Therapeutics (CDTX) United States $0.164B 0.00
Bellus Health (BLU) Canada $0.161B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
TELA Bio (TELA) United States $0.153B 0.00
Applied Genetic Technologies (AGTC) United States $0.152B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.146B 0.00
Nicox SA (NICXF) France $0.146B 0.00
VolitionRX (VNRX) United States $0.144B 0.00
Gritstone Oncology (GRTS) United States $0.140B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.139B 0.00
Celyad SA (CYAD) Belgium $0.138B 0.00
Palatin Technologies (PTN) United States $0.133B 3.40
Cardiff Oncology (CRDF) United States $0.129B 0.00
Lumos Pharma (LUMO) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.127B 6.45
Oncobiologics (OTLK) United States $0.124B 0.00
Enzo Biochem (ENZ) United States $0.122B 0.00
PHASEBIO PHARMA (PHAS) United States $0.122B 0.00
Windtree Therapeutics (WINT) United States $0.121B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Checkpoint Therapeutics (CKPT) United States $0.118B 0.00
SESEN BIO, INC (SESN) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.116B 0.00
Cocrystal Pharma (COCP) United States $0.112B 0.00
CorMedix Inc (CRMD) United States $0.111B 0.00
Antibe Therapeutics (ATBPF) Canada $0.102B 0.00
ARAVIVE, INC (ARAV) United States $0.096B 0.00
Vaccinex (VCNX) United States $0.095B 0.00
AIT Therapeutics (XAIR) United States $0.095B 0.00
AnPac Bio-Medical Science (ANPC) China $0.090B 0.00
Organovo Holdings (ONVO) United States $0.089B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.085B 0.00
Unum Therapeutics (UMRX) United States $0.082B 0.00
DiaMedica Therapeutics (DMAC) United States $0.081B 0.00
AquaBounty Technologies (AQB) United States $0.081B 0.00
Synlogic (SYBX) United States $0.081B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Idera Pharmaceuticals (IDRA) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Edesa Biotech (EDSA) Canada $0.074B 0.00
Proteostasis Therapeutics (PTI) United States $0.074B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.070B 0.00
Catalyst Biosciences (CBIO) United States $0.068B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 97.50
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Soligenix (SNGX) United States $0.067B 0.00
Signal Genetics (MGEN) United States $0.066B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.065B 0.00
IMMURON (IMRN) Australia $0.062B 0.00
Happiness Biotech Group (HAPP) China $0.059B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
Genetic Technologies (GENE) Australia $0.054B 0.00
Prima BioMed (IMMP) Australia $0.053B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
Apricus Biosciences (SEEL) United States $0.051B 0.00
Curis (CRIS) United States $0.049B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Novogen (KZIA) Australia $0.043B 0.00
Spherix (AIKI) United States $0.043B 0.00
Cesca Therapeutics (THMO) United States $0.041B 0.00
Prana Biotechnology (ATHE) Australia $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
AmpliPhi Biosciences (ARMP) United States $0.039B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.036B 0.00
OvaScience (MLND) United States $0.036B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
Forte Biosciences (FBRX) United States $0.035B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
Cleveland BioLabs (CBLI) United States $0.033B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Evogene (EVGN) Israel $0.029B 0.00
Chanticleer Holdings (SONN) United States $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
AEterna Zentaris (AEZS) United States $0.023B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
MYOS RENS Technology (MYOS) United States $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00